openPR Logo
Press release

Global Companion diagnostics Market By Technology, Product Segmentation by Leading Players and Opportunity - Global Forecasts to 2022

10-10-2018 07:53 PM CET | Health & Medicine

Press release from: MarketResearchFuture

Global Companion diagnostics Market By Technology, Product

Pune, India, January, 2018/MRFR Press Release/- Market Research Future published a Half Cooked research report on “Global Companion diagnostics Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Abbott (U.S.), Agilent Technologies (U.S.), ARUP Laboratories (U.S.), F. Hoffmann-La Roche AG. (Germany), Myriad Genetics Inc. (U.S.), QIAGEN N.V. (Germany), and Thermo Fisher Scientific Inc. (U.S.). and others are some of the prominent players at the forefront of competition in the global companion diagnostics market and are profiled in MRFR Analysis. 

Global Companion diagnostics Market - Overview

Companion Diagnostics is the as a bio-analytical method designed for the assessment of the patient to check whether patient responds to a specific medical treatment or not. Companion diagnostics are used to determine which patients are benefited from a certain type of medication or which therapies are best suited for the patients with certain medical conditions. Companion diagnostics involves tests and devices or tools which provide information about the safe and effective use of the specific therapeutic product. It not only provides information about the efficacy of the drugs but also the side effects that are associated with the drug. To control the rising cost of the drug discovery and development for the deadly and chronic diseases, the need for companion diagnostics is increasing; and with the increasing demand for the companion diagnostic tools and techniques, the global market for the companion diagnostics is growing.

Avail Sample for this report at: https://www.marketresearchfuture.com/sample_request/3077

Among all the regions in the world, the U.S. has been the first choice for a suitable deployment of companion diagnostic solutions due to the availability of established healthcare system and technological advancement.
Moreover, a number of CDx initiatives, research & development programs, product launch and diagnostic tools have emerged and lot many are still in the pipeline. The U.S. has gained significant pharmaceutical developments along with FDA approvals; patents and licensing that enable it to position itself in the global companion diagnostic market.

The global companion diagnostics market is expected to grow at a CAGR of 15.4% during forecasted period 2017-2023.

Industry Updates

December, 2016 Agilent Technologies announced the acquisition of Multiplicom N.V., a Leading European Diagnostics Company. The acquisition of Multiplicom significantly strengthens our presence in the genomics market

August, 2016 Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.

May, 2016 Myriad completes acquisition of Sividon Diagnostics. With this deal, company believes to strengthen its market leading oncology portfolio of high value personalized medicine products.

April, 2016 Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.  

August 2015 Roche Holdsing AG Roche acquires GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholdsers $190 million upfront and up to $235 million in contingent product related milestones.

Access Complete Report @ https://www.marketresearchfuture.com/reports/companion-diagnostic-market-3077

Global Companion diagnostics Market – Regional:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

The North America includes the U.S., and Canada; and presently, they together dominate the global companion diagnostic market. Further, South America comprises of countries such as Brazil, Peru, Columbia, and Panama among others, and they all contribute a very small share in the global companion diagnostic market.

Europe, accounts for the second largest, in the global companion diagnostics market. The European region includes both Western and Eastern European countries which are involved in development of companion diagnostics. The major countries in the Western Europe are Germany, France, UK, Italy, and Spain. These companion diagnostic solutions are increasing the efficiency of the healthcare workforce and systems driven by the increasing adoption of precise diagnostic tools, electronic healthcare records and drugs prescribed particularly for a disease.

Asia-Pacific region is estimated to be the fastest growing market due to continuous developments in developing countries like India and China. These countries are increasingly involved in the research and development of the companion diagnostic tools for the better medical outcomes, educating people regarding awareness, and also for treatment of crucial genetic diseases.On the other hand, there are some concerning factors such as lack of infrastructure with proper amenities for medical diagnosis and treatment, few healthcare workers, physicians, and health practitioners over large population may decelerate the growth of the companion diagnostic market to an extent.

The Middle East & Africa companion diagnostic market is in early stage. The efforts are being taken to spread the awareness about the importance of the Companion Diagnostic tools in these regions. However, at present, the growth in the Middle East & Africa companion diagnostic market is limited but steady.

Enquire for Discount at: https://www.marketresearchfuture.com/check-discount/3077

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact

Market Research Future

+1 646 845 9312

Email-  Sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Companion diagnostics Market By Technology, Product Segmentation by Leading Players and Opportunity - Global Forecasts to 2022 here

News-ID: 1294942 • Views:

More Releases from MarketResearchFuture

Miglitol Market Report Size, Share, and Forecast 2032 | Novartis ,Daiichi Sankyo ,Teva Pharmaceutical Industries
Miglitol Market Report Size, Share, and Forecast 2032 | Novartis ,Daiichi Sankyo …
According to WGR's most recent report, the Miglitol Market 2024-2032 is anticipated to grow rapidly over the coming years. Through the process of research, consolidation, market size, overview, and review of data obtained from multiple sources, the Miglitol Market report provides a meaningful representation of the region. In the Miglitol Market Study, you will find details about market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial
Smart Fleet Management Market Size, Share Demand Rising Worldwide 2030
Smart Fleet Management Market Size, Share Demand Rising Worldwide 2030
Market Outlook: The Smart Fleet Management market is estimated to attain a valuation of USD 605.7 billion by the end of 2030, states a study by Market research Future (MRFR). Besides, the report notes that the Smart Fleet Management market is prognosticated to expand at a CAGR of 10.1% during the forecast period, 2023-2030. Smart fleet management is experiencing significant market trends driven by advancements in technology and evolving industry needs. One
Automotive Heat Shield Market Size, Share, Demand Trends and Forecasts to 2032
Automotive Heat Shield Market Size, Share, Demand Trends and Forecasts to 2032
According to projections, the Automotive Heat Shield market will expand at a compound annual growth rate (CAGR) of 3.8% from USD 15825.1 million in 2021 to USD 18759.1 million in 2032. Heat shields are used to shield a device's internal components from heat produced by the core. In the automotive industry, the heat shield is utilized to reduce the excessive heat generated by internal combustion engines. Heat shields are most frequently
Automotive Filters Market Size, Share, Business Key Players, Forecast By 2032
Automotive Filters Market Size, Share, Business Key Players, Forecast By 2032
The size of the automotive Automotive Filters market was estimated at USD 25.1 billion in 2022. With a compound annual growth rate (CAGR) of 3.00% over the forecast period (2023-2032), the automotive Automotive Filters market industry is expected to expand from USD 25.8 billion in 2023 to USD 32.7 billion by 2032. The main factors propelling the market's expansion are rising sales, the need for automobile Automotive Filters, and the

All 5 Releases


More Releases for Companion

Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors. The Artificial Intelligence (AI) In Beauty and Cosmetics Market
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673 This latest report researches the industry structure, sales, revenue,
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test